Biofrontera (BFRIW) Receivables - Other (2020 - 2025)

Biofrontera's Receivables - Other history runs 6 years deep, the most recent figure standing at $4.8 million for Q4 2025.

• In Q4 2025, Receivables - Other fell 9.43% year-over-year to $4.8 million; the TTM figure through Dec 2025 stood at $4.8 million (down 9.43% YoY), while the FY2025 annual figure was $4.8 million, down 9.43% from the prior year.
• Receivables - Other was $4.8 million for Q4 2025 at Biofrontera, up from $200000.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $8.6 million in Q4 2021 to a low of $56000.0 in Q3 2021.
• Historically, Receivables - Other has averaged $3.2 million across 5 years, with a median of $3.4 million in 2022.
• The sharpest annual moves came in 2021 and 2024: Receivables - Other soared 11745.21% in 2021, then plunged 95.44% in 2024.
• A 5-year view of Receivables - Other shows it stood at $8.6 million in 2021, then tumbled by 57.7% to $3.7 million in 2022, then fell by 23.46% to $2.8 million in 2023, then soared by 89.29% to $5.3 million in 2024, then dropped by 9.43% to $4.8 million in 2025.
• The last three Receivables - Other figures came in at $4.8 million (Q4 2025), $200000.0 (Q1 2025), and $5.3 million (Q4 2024), per Business Quant data.